Webinar description: What risks does RbM introduce by itself? Why monitoring team does not accept the new RbM procedure? How should sites be involved in RbM process? Now, we can tackle these questions. We are going to review the definition of Risk-based Monitoring (RbM) in [...]
If not applied appropriately, Risk-based Monitoring could generate certain risks that influence data quality and patient safety inversely. Adopting an RBM approach involves more than applying some 'formula'. This white paper lists the 8 most common pitfalls of RBM implementation and expert suggestions on how to avoid them.
Case Study Clinical trial site engagement has been advocated as a critical component relating to a study’s performance and success, however, a minimum amount of data supports this connection. In this article a reader will find quantitative and qualitative approach based on risk-based [...]
In Applied Clinical Trials journal appeared an article, which investigates the question of site screening due diligence and how it can improve patient dropout rates - "RbM Data Reveals Site Screening Due Diligence Improves Patient Dropout and Retention". The investigations for the article were done applying [...]